HSE to extend Soliris drug to PNH & aHUS patients – Deering
4th February 2015 - Fine Gael Press Office
Fine Gael Carlow/ Kilkenny TD, Pat Deering, has today (Wednesday) welcomed confirmation from the HSE that they are to extend access to the drug Eculizumab (trading as Soliris), for patients with the conditions Paroxysmal Nocturnal Hemoglobinuria (PNH) and atypical Haemolytic Uraemic (aHUS).
“I have been advocating for this drug to be State funded ever since I heard the story of Ballinakill woman Mary Gorman who has PNH, a very rare and debilitating disease.
Related news
The GPO needs to be a place for every child to visit in school - Geoghegan
The Government needs to be bold in its redevelopment of the GPO for future generations, a Fine Gael TD has…
23rd June 2026Senator Garret Ahearn appointed Leader of Seanad Éireann
Senator Garret Ahearn has been appointed Leader of the Seanad by Tánaiste Simon Harris. The appointment was made to fill…
17th June 2026Fine Gael commemorates centenary of former Taoiseach Garret FitzGerald
Fine Gael marked the 100th anniversary of the birth of former Taoiseach Garret FitzGerald with a special event in Dublin today.…
14th June 2026